The Dow Jones Industrial Average outperformed along with small caps Friday as investors weighed new inflation data alongside more strength in Chinese stocks on the stock market today.
↑ XThe Dow was up 0.5%, helped by strong early gains from Visa (V) and Intel (INTC). The blue-chip index has rallied powerfully since a bullish upside reversal on Sept. 11. It's a leading index now, along with the S&P 500, which marked another all-time closing high Thursday.
The S&P 500 and Nasdaq composite edged higher by 0.1%. Casino operators with exposure to China rose sharply in the S&P 500. Wynn Resorts (WYNN), Las Vegas Sands (LVS) and MGM Resorts (MGM) showed gains of at least 4%.
Nvidia weighed on the Nasdaq with a drop of 1.5%. The artificial intelligence bellwether is still holding above its 50-day moving average after three straight gains.
Bristol Myers Squibb (BMY) was another top gainer on the S&P 500, up more than 1%. The drugmaker broke out over the 51 level but fell sharply off highs. Sentiment was positive after the Food and Drug Administration approved the company's Cobenfy as a schizophrenia treatment for adults.
Breadth was more than 2-to-1 positive on the Nasdaq exchange and nearly 4-to-1 positive on the New York Stock Exchange.
Small caps also outperformed, with the Russell 2000 up 0.7%.
After soaring 11.5% Thursday, the Crane CSI China Internet (KWEB) exchange traded fund was up another 4% on the stock market today, bringing its weekly gain to more than 25%. The fund is at nosebleed levels at this point, more than 25% above its 50-day moving average.
Stay In Sync With The Market With IBD's ETF Market Strategy
Chinese indexes soared again overnight. The Shanghai composite jumped another 2.9% and the Hang Seng Index surged 3.5%. Earlier in the week, China announced a round of new stimulus measures. Reports Thursday said that China is also considering injecting more than $100 billion into the country's top banks.
China-listed names like New Oriental Education (EDU), Trip.com (TCOM), Bilibili (BILI) and Baidu (BIDU) showed early gains of around 4% Thursday.
In economic news, personal income came in weaker than expected, rising 0.2% in August. That was below the 0.4% consensus. But inflation data inside the personal income and spending report didn't sound any alarms. On a year over year basis, the core personal consumption index increased 2.7%, in line with views but slightly above July's reading of 2.6%.
Inside the MarketSurge Growth 250, Ensign Group (ENSG) was down 1% on news it's moving to the S&P MidCap 400 from the S&P SmallCap 600 effective Oct. 1. The MidCap 400 isn't as widely held as the SmallCap 600. Ensign's price decline is a result of more small-cap funds selling shares than mid-cap funds buying.
Fast-growing Oscar Health (OSCR) also outperformed on the stock market today with a gain of more than 4% After five straight declines, the stock is making a stand at its 21-day exponential moving average.
Follow Ken Shreve on X @IBD_KShreve for more stock market analysis and insight.
YOU MAY ALSO LIKE:
Why This IBD Tool Simplifies The Search For Top Stocks
Catch The Next Big Winning Stock With MarketSurge
Want To Get Quick Profits And Avoid Big Losses? Try SwingTrader
Best Growth Stocks To Buy And Watch
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.